chronic myelomonocytic leukemia
Showing NaN - NaN of 13
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)
Active, not recruiting
- Myelofibrosis
- Chronic Myelomonocytic Leukemia
-
Duarte, California
- +9 more
Jan 24, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
-
Fountain Valley, California
- +28 more
Nov 18, 2022
Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in
Completed
- Acute Myeloid Leukemia
- +5 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 4, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in United States (ASTX727 + Day 2 Food, ASTX727 + Day 4 Food)
Completed
- Myelodysplastic Syndromes
- +2 more
- ASTX727 + Day 2 Food
- ASTX727 + Day 4 Food
-
Buffalo, New York
- +3 more
Feb 16, 2020
Acute Myeloid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Buffalo
Completed
- Acute Myeloid Leukemia
- +4 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 16, 2020
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +99 more
- fludarabine phosphate
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 30, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +77 more
- fludarabine phosphate
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 16, 2019
Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Buffalo, London, Toronto (sunitinib malate)
Completed
- Chronic Myelomonocytic Leukemia
- +3 more
- sunitinib malate
-
Buffalo, New York
- +3 more
Jul 27, 2018
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +14 more
- Azacitidine
- +2 more
-
Scottsdale, Arizona
- +233 more
Dec 8, 2016
Chronic Myelomonocytic Leukemia Trial in Buffalo, Portland, Salt Lake City (5-Azacitidine)
Completed
- Chronic Myelomonocytic Leukemia
-
Buffalo, New York
- +2 more
May 10, 2016